Report Detail
Global Capecitabine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4656097 |
- 05 December, 2025 |
- Global |
- 89 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Capecitabine market size was valued at US$ 1048 million in 2024 and is forecast to a readjusted size of USD 1020 million by 2031 with a CAGR of -0.4% during review period.
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.
Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.
This report is a detailed and comprehensive analysis for global Capecitabine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Capecitabine market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Capecitabine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Capecitabine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Capecitabine market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Capecitabine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Capecitabine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Teva, Mylan, Hikma, Hengrui Medicine, Cipla, Reliance Group, Hetero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Capecitabine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
500 mg
150 mg
Market segment by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer
Major players covered
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Capecitabine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Capecitabine, with price, sales quantity, revenue, and global market share of Capecitabine from 2020 to 2025.
Chapter 3, the Capecitabine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Capecitabine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Capecitabine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Capecitabine.
Chapter 14 and 15, to describe Capecitabine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Capecitabine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 500 mg
- 1.3.3 150 mg
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Capecitabine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Breast Cancer
- 1.4.3 Colorectal Cancer
- 1.4.4 Stomach Cancer
- 1.5 Global Capecitabine Market Size & Forecast
- 1.5.1 Global Capecitabine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Capecitabine Sales Quantity (2020-2031)
- 1.5.3 Global Capecitabine Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Capecitabine Product and Services
- 2.1.4 Roche Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Teva
- 2.2.1 Teva Details
- 2.2.2 Teva Major Business
- 2.2.3 Teva Capecitabine Product and Services
- 2.2.4 Teva Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Teva Recent Developments/Updates
- 2.3 Mylan
- 2.3.1 Mylan Details
- 2.3.2 Mylan Major Business
- 2.3.3 Mylan Capecitabine Product and Services
- 2.3.4 Mylan Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Mylan Recent Developments/Updates
- 2.4 Hikma
- 2.4.1 Hikma Details
- 2.4.2 Hikma Major Business
- 2.4.3 Hikma Capecitabine Product and Services
- 2.4.4 Hikma Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Hikma Recent Developments/Updates
- 2.5 Hengrui Medicine
- 2.5.1 Hengrui Medicine Details
- 2.5.2 Hengrui Medicine Major Business
- 2.5.3 Hengrui Medicine Capecitabine Product and Services
- 2.5.4 Hengrui Medicine Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Hengrui Medicine Recent Developments/Updates
- 2.6 Cipla
- 2.6.1 Cipla Details
- 2.6.2 Cipla Major Business
- 2.6.3 Cipla Capecitabine Product and Services
- 2.6.4 Cipla Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Cipla Recent Developments/Updates
- 2.7 Reliance Group
- 2.7.1 Reliance Group Details
- 2.7.2 Reliance Group Major Business
- 2.7.3 Reliance Group Capecitabine Product and Services
- 2.7.4 Reliance Group Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Reliance Group Recent Developments/Updates
- 2.8 Hetero
- 2.8.1 Hetero Details
- 2.8.2 Hetero Major Business
- 2.8.3 Hetero Capecitabine Product and Services
- 2.8.4 Hetero Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Hetero Recent Developments/Updates
3 Competitive Environment: Capecitabine by Manufacturer
- 3.1 Global Capecitabine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Capecitabine Revenue by Manufacturer (2020-2025)
- 3.3 Global Capecitabine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Capecitabine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Capecitabine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Capecitabine Manufacturer Market Share in 2024
- 3.5 Capecitabine Market: Overall Company Footprint Analysis
- 3.5.1 Capecitabine Market: Region Footprint
- 3.5.2 Capecitabine Market: Company Product Type Footprint
- 3.5.3 Capecitabine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Capecitabine Market Size by Region
- 4.1.1 Global Capecitabine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Capecitabine Consumption Value by Region (2020-2031)
- 4.1.3 Global Capecitabine Average Price by Region (2020-2031)
- 4.2 North America Capecitabine Consumption Value (2020-2031)
- 4.3 Europe Capecitabine Consumption Value (2020-2031)
- 4.4 Asia-Pacific Capecitabine Consumption Value (2020-2031)
- 4.5 South America Capecitabine Consumption Value (2020-2031)
- 4.6 Middle East & Africa Capecitabine Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Capecitabine Sales Quantity by Type (2020-2031)
- 5.2 Global Capecitabine Consumption Value by Type (2020-2031)
- 5.3 Global Capecitabine Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Capecitabine Sales Quantity by Application (2020-2031)
- 6.2 Global Capecitabine Consumption Value by Application (2020-2031)
- 6.3 Global Capecitabine Average Price by Application (2020-2031)
7 North America
- 7.1 North America Capecitabine Sales Quantity by Type (2020-2031)
- 7.2 North America Capecitabine Sales Quantity by Application (2020-2031)
- 7.3 North America Capecitabine Market Size by Country
- 7.3.1 North America Capecitabine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Capecitabine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Capecitabine Sales Quantity by Type (2020-2031)
- 8.2 Europe Capecitabine Sales Quantity by Application (2020-2031)
- 8.3 Europe Capecitabine Market Size by Country
- 8.3.1 Europe Capecitabine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Capecitabine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Capecitabine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Capecitabine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Capecitabine Market Size by Region
- 9.3.1 Asia-Pacific Capecitabine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Capecitabine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Capecitabine Sales Quantity by Type (2020-2031)
- 10.2 South America Capecitabine Sales Quantity by Application (2020-2031)
- 10.3 South America Capecitabine Market Size by Country
- 10.3.1 South America Capecitabine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Capecitabine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Capecitabine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Capecitabine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Capecitabine Market Size by Country
- 11.3.1 Middle East & Africa Capecitabine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Capecitabine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Capecitabine Market Drivers
- 12.2 Capecitabine Market Restraints
- 12.3 Capecitabine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Capecitabine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Capecitabine
- 13.3 Capecitabine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Capecitabine Typical Distributors
- 14.3 Capecitabine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Capecitabine. Industry analysis & Market Report on Capecitabine is a syndicated market report, published as Global Capecitabine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Capecitabine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
